- Home
- CULP vs ATYR Comparison
CULP vs ATYR Comparison
Compare CULP & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CULP | ATYR |
|---|---|---|
| Founded | 1972 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8M | 49.2M |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CULP | ATYR |
|---|---|---|
| Price | $3.53 | $0.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $2.86 |
| AVG Volume (30 Days) | 60.5K | ★ 1.8M |
| Earning Date | 12-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.06 | 6.98 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $203,482,000.00 | $190,000.00 |
| Revenue This Year | $3.15 | N/A |
| Revenue Next Year | $1.77 | N/A |
| P/E Ratio | $7.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.70 | $0.16 |
| 52 Week High | $4.25 | $1.11 |
Technical Indicators
Market Signals| Indicator | CULP | ATYR |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 12.36 |
| Support Level | $3.45 | N/A |
| Resistance Level | $3.59 | $0.60 |
| Average True Range (ATR) | 0.20 | 0.02 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 18.50 | 2.55 |
Price Performance
Historical ComparisonAbout CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.
About ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).